Putting the ‘person’ at the heart of patient centricity – why language mattersThe irony of patient centricity is its name – that a movement designed to help people look after Share XPutting the ‘person’ at the heart of patient centricity – why language mattershttps://pharmaphorum.com/views-analysis-patients/putting-person-heart-patient-centricity/
Balancing expectations: An unmet need in the orphan disease arenaThere are between 6000 and 8000 rare diseases in the world, and one in ten people in Europe Share XBalancing expectations: An unmet need in the orphan disease arenahttps://pharmaphorum.com/views-analysis-market-access/balancing-expectations-rare-disease-arena/
Why pharma’s focus on patients requires less patienceHave you missed me? I certainly wouldn’t be so egotistical to assume that anyone has, but bizarrely it’s Share XWhy pharma’s focus on patients requires less patiencehttps://pharmaphorum.com/patients/pharmas-focus-patients-requires-less-patience/
Collaboration can ensure access to life-changing innovationAs a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new Share XCollaboration can ensure access to life-changing innovationhttps://pharmaphorum.com/views-analysis-market-access/access-life-changing-innovation-risk-sharing-scheme/
Listening to the Patient Voice: seek out the quietest voice to meet the biggest needThe success or failure of patient centricity rests on getting the patient voice in the mix – not Share XListening to the Patient Voice: seek out the quietest voice to meet the biggest needhttps://pharmaphorum.com/views-analysis-patients/listening-patient-voice/
A global outlook: government affairs and policyMerck KGaA, Darmstadt, Germany’s Lynn Taylor talked to pharmaphorum about the challenges facing the government affairs and policy Share XA global outlook: government affairs and policyhttps://pharmaphorum.com/views-analysis-patients/a-global-outlook-government-affairs-and-policy/
Raising awareness about rare diseasesA family tragedy has prompted Kay Parkinson, founder of the rare disease charity Alstrom Syndrome UK, to create Share XRaising awareness about rare diseaseshttps://pharmaphorum.com/views-analysis-patients/awareness-rare-diseases/
How people power is building patient-centric pharmaWhile everyone is agreed on the importance of patient-centric pharma, just one fifth of industry insiders said they Share XHow people power is building patient-centric pharmahttps://pharmaphorum.com/views-analysis-patients/how-people-power-is-building-patient-centric-pharma/
What next for joint working that really improves patient outcomes?Joint working has become something of the norm in the last decade, but have we taken the time Share XWhat next for joint working that really improves patient outcomes?https://pharmaphorum.com/views-analysis-patients/what-next-joint-working-improves-patient-outcomes/
